Strategic GI Oncology Clinical Science Leader

Merck; South San Francisco (CA); Hybride; USD 210 000 - 331 000; Plein temps

Résumé du poste

Merck in South San Francisco, CA, seeks a Senior Director of Clinical Science for GI Oncology to provide strategic leadership across multiple studies and assets. The role reports to the Executive Director and shapes disease-area strategy, scientific standards, and medical data review across the portfolio.

You will partner with cross-functional leaders to guide development planning, clinical data interpretation, and governance discussions, while promoting innovative analytics and high-quality

Qualifications

• Significant experience in Clinical Development and leadership of Clinical Science.
• Proven ability to lead across multiple studies, programs or assets.
• Deep GI Oncology therapeutic area expertise and data review experience.
• Excellent communication and executive presentation skills.

Responsabilités

• Provide strategic Clinical Science leadership across GI Oncology studies and assets.
• Guide development planning, data interpretation, and governance discussions.
• Partner with Section Heads, Asset Leads and cross-functional leaders to align activities.
• Apply therapeutic knowledge to inform study planning and endpoints.
• Mentor clinical scientists and foster capability building across the team.

Connaissances

Clinical Sciences

Clinical Trial Planning

Oncology

People Leadership

Study Design

Trial Design

Matrix Management

Life Science

Therapeutic Knowledge

Clinical Research Management

Formation

PhD or PharmD

Master's degree with 12+ years

Bachelor's degree with 15+ years

Description du poste

Merck in South San Francisco, CA, seeks a Senior Director of Clinical Science for GI Oncology to provide strategic leadership across multiple studies and assets. The role reports to the Executive Director and shapes disease-area strategy, scientific standards, and medical data review across the portfolio.

You will partner with cross-functional leaders to guide development planning, clinical data interpretation, and governance discussions, while promoting innovative analytics and high-quality